- Patent Title: Pharmaceutical compositions containing anti-beta amyloid antibodies
-
Application No.: US16639338Application Date: 2018-08-22
-
Publication No.: US11655289B2Publication Date: 2023-05-23
- Inventor: Steven Andrew Lantz , Kapil Gupta , Shantanu Sule , Adnan Zunic
- Applicant: Biogen MA Inc.
- Applicant Address: US MA Cambridge
- Assignee: Biogen MA Inc.
- Current Assignee: Biogen MA Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Choate, Hall & Stewart LLP
- Agent Stephanie L. Schonewald; Tracy L. Vrablik
- International Application: PCT/US2018/047508 2018.08.22
- International Announcement: WO2019/040612A 2019.02.28
- Date entered country: 2020-02-14
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; A61K47/18 ; A61K47/20 ; A61K47/22 ; A61K47/26 ; A61K39/00
Abstract:
Pharmaceutical compositions containing anti-beta amyloid (Aβ) antibodies or AD-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of Aβ in the central nervous system, mild cognitive impairment, and AD-associated disorders such as Alzheimer's disease.
Public/Granted literature
- US20210188954A1 PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES Public/Granted day:2021-06-24
Information query
